Cell or Cell Membrane-Based Drug Delivery Systems
暂无分享,去创建一个
Zhiping Zhang | Songwei Tan | Zhiping Zhang | Tingting Wu | Tingting Wu | Dan Zhang | Songwei Tan | Dan Zhang
[1] James J Moon,et al. Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.
[2] Donghong Zhao,et al. Neural Stem Cell-Mediated Intratumoral Delivery of Gold Nanorods Improves Photothermal Therapy , 2014, ACS nano.
[3] S. Grimaldi,et al. Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus. , 1997, Antiviral research.
[4] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[5] J. M. Lanao,et al. Drug, enzyme and peptide delivery using erythrocytes as carriers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[6] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[7] Ronnie H. Fang,et al. Liposome-like Nanostructures for Drug Delivery. , 2013, Journal of materials chemistry. B.
[8] M. Segura,et al. Interaction of Mouse Dendritic Cells and Malaria-Infected Erythrocytes: Uptake, Maturation, and Antigen Presentation1 , 2006, The Journal of Immunology.
[9] Vipul Gujrati,et al. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. , 2014, ACS nano.
[10] Seung U. Kim,et al. Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[11] Ralph Weissleder,et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.
[12] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[13] B. Badie,et al. Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[14] Peter Y. Li,et al. Structural elucidation of cell membrane-derived nanoparticles using molecular probes. , 2014, Journal of materials chemistry. B.
[15] Olivier Lantz,et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.
[16] C. Théry,et al. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.
[17] J. Le Pecq,et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.
[18] Cesar M. Castro,et al. Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles. , 2013, ACS nano.
[19] Ronnie H. Fang,et al. Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.
[20] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[21] Ronnie H. Fang,et al. Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery , 2014, Nano letters.
[22] H. Gendelman,et al. Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.
[23] M. Rumbo,et al. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection. , 2013, Vaccine.
[24] Samir Mitragotri,et al. Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation , 2007, Experimental biology and medicine.
[25] M. Kim,et al. The influence of amphotericin B on the permeability of mammalian erythrocytes to nonelectrolytes, anions and cations , 1973 .
[26] Shinobu Ueda,et al. Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[27] S. Vinogradov,et al. Macrophages associated with tumors as potential targets and therapeutic intermediates. , 2014, Nanomedicine.
[28] Jian Song,et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.
[29] A Herráez,et al. In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross‐linking or diamide treatment , 2001, Biotechnology and applied biochemistry.
[30] R. Simpson,et al. Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.
[31] Ronnie H. Fang,et al. Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. , 2013, Nanomedicine.
[32] R. Kerbel,et al. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR , 2009, Proceedings of the National Academy of Sciences.
[33] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[34] Helmuth Möhwald,et al. Red blood cells and polyelectrolyte multilayer capsules: natural carriers versus polymer-based drug delivery vehicles , 2013, Expert opinion on drug delivery.
[35] Dong Chen,et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. , 2011, ACS nano.
[36] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[37] S. Kesari,et al. Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[38] Sang Joon Lee,et al. Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging. , 2011, Biomaterials.
[39] C. Figdor,et al. Dendritic cell-based nanovaccines for cancer immunotherapy. , 2013, Current opinion in immunology.
[40] Feng Gao,et al. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. , 2014, ACS nano.
[41] T. Tsong,et al. Electroporation of cell membranes. , 1991, Biophysical journal.
[42] S Gasic,et al. In vivo clearance of antibody‐sensitized human drug carrier erythrocytes , 1986, Clinical pharmacology and therapeutics.
[43] Ronnie H. Fang,et al. Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. , 2014, Nanoscale.
[44] Jaesung Park,et al. Large-scale generation of cell-derived nanovesicles. , 2014, Nanoscale.
[45] Jing Chen,et al. RAFTsomes Containing Epitope-MHC-II Complexes Mediated CD4+ T Cell Activation and Antigen-Specific Immune Responses , 2012, Pharmaceutical Research.
[46] Marcelle Machluf,et al. Reconstructed stem cell nanoghosts: a natural tumor targeting platform. , 2013, Nano letters.
[47] C. Heirman,et al. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. , 2012, Cancer research.
[48] F. Ahsan,et al. Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and Characterization , 2014, Pharmaceutical Research.
[49] Ronnie H. Fang,et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. , 2013, Nanoscale.
[50] Liangfang Zhang,et al. Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.
[51] Jiangxia Liu,et al. Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity , 2013, Nature Immunology.
[52] Shunsuke Noguchi,et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[53] Laurence Zitvogel,et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.
[54] F. Rico,et al. Structural and mechanical heterogeneity of the erythrocyte membrane reveals hallmarks of membrane stability. , 2013, ACS nano.
[55] Jaesung Park,et al. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. , 2014, Lab on a chip.
[56] Y. Gho,et al. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes , 2013, Proteomics.
[57] Q. Dong,et al. Monitoring diclofenac sodium in single human erythrocytes introduced by electroporation using capillary zone electrophoresis with electrochemical detection , 2001, Electrophoresis.
[58] Bahman Anvari,et al. Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications , 2013, Scientific Reports.
[59] R. Schiffelers,et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[60] S. Ritter,et al. Encapsulation of FITC to monitor extracellular pH: a step towards the development of red blood cells as circulating blood analyte biosensors , 2011, Biomedical optics express.
[61] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] Ronnie H. Fang,et al. A biomimetic nanosponge that absorbs pore-forming toxins , 2013, Nature nanotechnology.
[63] Antonella Antonelli,et al. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. , 2011, Nanomedicine.
[64] M. Watanabe,et al. Regulatory T cells and breast cancer: implications for immunopathogenesis , 2010, Cancer and Metastasis Reviews.
[65] E. Terreno,et al. Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents. , 2014, Journal of the American Chemical Society.
[66] Jennifer Sturgis,et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.
[67] P. Kantoff,et al. Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer , 2012, Cancer Immunology, Immunotherapy.
[68] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[69] M. Andreeff,et al. Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. , 2013, Cytotherapy.
[70] Guimei Zhang,et al. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles , 2012, Nature Communications.
[71] Hon-Man Liu,et al. Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells , 2010, Nanotechnology.
[72] Silvia Maria Doglia,et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[73] Y. Tabata,et al. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. , 2012, Molecular pharmaceutics.
[74] Zhiping Zhang,et al. Lipid-enveloped hybrid nanoparticles for drug delivery. , 2013, Nanoscale.
[75] Ronnie H. Fang,et al. Nanoparticle-detained toxins for safe and effective vaccination , 2013, Nature nanotechnology.
[76] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[77] Ronnie H. Fang,et al. 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.
[78] Laura Chiarantini,et al. Erythrocytes deliver Tat to interferon‐γ‐treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro , 2002, Journal of leukocyte biology.
[79] QUAN LIU,et al. Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[80] Y. Tao,et al. A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[81] S. Kesari,et al. Distearoyl Anchor‐Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo , 2014, Advanced healthcare materials.
[82] Jörg Huwyler,et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[83] Y. Sung,et al. The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity , 2011, Gene Therapy.
[84] Robert Franco,et al. International seminar on the red blood cells as vehicles for drugs , 2012, Expert opinion on biological therapy.
[85] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[86] A. Bangham. Surrogate cells or Trojan horses. The discovery of liposomes. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[87] Y. Sung,et al. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells. , 2011, Human gene therapy.
[88] Robert Langer,et al. Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. , 2013, Molecular pharmaceutics.
[89] Kostas Kostarelos,et al. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. , 2011, Accounts of chemical research.
[90] H. Choi,et al. Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. , 2013, Biomaterials.
[91] A. Kabanov,et al. Cell-mediated drug delivery to the brain , 2013 .
[92] M. Stojkovic,et al. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice , 2013, Scientific Reports.
[93] Jaesung Park,et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.
[94] G. Bosman,et al. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion , 2008, Transfusion medicine.
[95] J. M. Lanao,et al. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. , 2004, Blood cells, molecules & diseases.
[96] P. A. van der Ley,et al. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes. , 2014, Vaccine.
[97] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[98] Xingzhong Zhao,et al. Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery. , 2014, ACS nano.
[99] J. Hubbell,et al. Engineering antigens for in situ erythrocyte binding induces T-cell deletion , 2012, Proceedings of the National Academy of Sciences.
[100] J. Hubbell,et al. Translating materials design to the clinic. , 2013, Nature materials.
[101] Ronnie H. Fang,et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. , 2013, Nanoscale.
[102] N. Guérin,et al. Red blood cells as innovative antigen carrier to induce specific immune tolerance. , 2013, International journal of pharmaceutics.
[103] Lei Chen,et al. Tumor microenviroment and hepatocellular carcinoma metastasis , 2013, Journal of gastroenterology and hepatology.
[104] J. Berlin,et al. Gold Nanoparticle‐Loaded Neural Stem Cells for Photothermal Ablation of Cancer , 2013, Advanced healthcare materials.
[105] Kam W. Leong,et al. Whole Blood Cells Loaded with Messenger RNA as an Anti‐Tumor Vaccine , 2014, Advanced healthcare materials.
[106] M. Wood,et al. Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.
[107] Weihong Tan,et al. Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system Review , 2008 .
[108] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[109] J. Shang,et al. Adenoviral‐mediated interleukin‐18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats , 2009, Cell biology international.
[110] Samir Mitragotri,et al. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. , 2013, ACS nano.
[111] C. Lewis,et al. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.
[112] F. Dosio,et al. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.
[113] M. Magnani,et al. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. , 2002, Antiviral research.
[114] M. Rouini,et al. In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat , 2001, Drug delivery.
[115] W. Grizzle,et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.
[116] T. Pellegrino,et al. Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. , 2013, Nanoscale.
[117] M. Magnani,et al. Preparation and characterization of biotinylated red blood cells , 1994, Biotechnology and applied biochemistry.
[118] J. Xiang,et al. GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses. , 2011, Vaccine.
[119] Mehrdad Hamidi,et al. Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[120] Mauro Magnani,et al. Drug delivery by red blood cells , 2011, IUBMB life.
[121] Mingying Yang,et al. Stem Cells Loaded with Nanoparticles as a Drug Carrier for In Vivo Breast Cancer Therapy , 2014, Advanced materials.
[122] J. C. Diez,et al. In vivo behaviour of rat band 3 cross-linked carrier erythrocytes. , 1998, Biochimie.
[123] S. Feng,et al. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success , 2013, Expert opinion on drug delivery.
[124] Xiaoqi Sun,et al. Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of Cancer , 2014, Advanced materials.
[125] Yuliang Zhao,et al. A membrane vesicle-based dual vaccine against melanoma and Lewis lung carcinoma. , 2012, Biomaterials.
[126] C Lizano,et al. In vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedure. , 1998, Biochimica et biophysica acta.
[127] Ronnie H. Fang,et al. Clearance of pathological antibodies using biomimetic nanoparticles , 2014, Proceedings of the National Academy of Sciences.
[128] E. L. Wright,et al. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[129] J. Berlin,et al. Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution. , 2014, Future oncology.
[130] C. Ménager,et al. Red blood cells decorated with functionalized core-shell magnetic nanoparticles: elucidation of the adsorption mechanism. , 2013, Chemical communications.
[131] R H Glew,et al. Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[132] Alexander M Seifalian,et al. The application of exosomes as a nanoscale cancer vaccine , 2010, International journal of nanomedicine.
[133] N. Jain,et al. Erythrocytes as carriers of primaquine-preparation: characterization and evaluation , 1992 .
[134] R. Weissleder,et al. 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. , 2011, Bioconjugate chemistry.
[135] Samir Mitragotri,et al. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[136] U. Şahin,et al. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. , 2010, Cancer research.
[137] S. Shimato,et al. Human neural stem cells transduced with IFN-β and cytosine deaminase genes intensify bystander effect in experimental glioma , 2010, Cancer Gene Therapy.
[138] Harvey F Lodish,et al. Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes , 2014, Proceedings of the National Academy of Sciences.
[139] Aled Clayton,et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.
[140] P. Lønning,et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.
[141] Khalid Shah,et al. Stem cell-based therapies for cancer treatment: separating hope from hype , 2014, Nature Reviews Cancer.
[142] Helmuth Möhwald,et al. Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells. , 2012, ACS nano.
[143] Pieter Vader,et al. Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[144] R. Flower,et al. Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. , 2008, Investigative ophthalmology & visual science.